Boston Scientific Acquires Sadra Medical for $193M

Boston Scientific Corporation BSX today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010. Under the terms of the agreement, Boston Scientific paid $193 million to acquire the remaining 86 percent of Sadra Medical's equity not already owned by Boston Scientific. Additional payments of up to $193 million are contingent upon achievement of specified regulatory and revenue-based criteria through 2016. The Company expects the acquisition to be approximately one to two cents dilutive to GAAP and adjusted earnings per share in 2011, 2012 and 2013, and accretive thereafter.